29.53

0.27% -0.08

After Hours: 29.53

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $29.53, with a volume of 327.85K. It is down -0.27% in the last 24 hours and down -5.32% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Previous Close:

$29.61

Open:

$29.91

24h Volume:

327.85K

Relative Volume:

0.53

Market Cap:

$1.47B

Revenue:

$534.53M

Net Income/Loss:

$-11.45M

P/E Ratio:

-122.48

EPS:

-0.2411

Net Cash Flow:

$48.28M

1W Performance:

+2.36%

1M Performance:

-5.32%

6M Performance:

-15.70%

1Y Performance:

-15.27%

1-Day Range:

$29.07

$30.67

1-Week Range:

$28.41

$30.67

52-Week Range:

$28.29

$43.18

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1114)

Industry

Medical Instruments & Supplies (58)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,350

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Compare ATRC vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATRC Atricure Inc	29.53	1.47B	534.53M	-11.45M	48.28M	-0.2411
ISRG Intuitive Surgical Inc	469.98	167.61B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	158.27	44.35B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.26	36.19B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	42.67	34.11B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	226.31	33.24B	5.40B	1.49B	1.78B	10.12

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-18-26	Downgrade	Oppenheimer	Outperform → Perform
Feb-11-26	Downgrade	JP Morgan	Overweight → Neutral
Dec-17-24	Resumed	JP Morgan	Overweight
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-29-23	Initiated	UBS	Buy
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

Mar 23, 2026

AtriCure, Inc. Experiences Revision in Stock Evaluation Amidst Market Challenges - Markets Mojo

Mar 23, 2026

AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? - AOL.com

Mar 23, 2026

Mar 22, 2026

MACD Signal: Should value investors consider AtriCure Inc2026 Retail Activity & Weekly High Return Forecasts - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

DAFNA Capital Management Sells Axogen Shares in 2025News and Statistics - IndexBox

Mar 21, 2026

ATRC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 21, 2026

Market Wrap: Is now the right time to enter AtriCure IncPortfolio Return Report & Accurate Intraday Trading Signals - baoquankhu1.vn

Mar 21, 2026

Mar 18, 2026

AtriCure Chief Scientific Officer Stock SaleMarch 2026 Transaction DetailsNews and Statistics - IndexBox

Mar 18, 2026

AtriCure unveils case-based training to build Afib program skills - Traders Union

Mar 18, 2026

AtriCure Stock Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Mar 18, 2026

Aug Patterns: Is AtriCure Inc undervalued by DCF analysisMarket Weekly Review & Weekly High Momentum Picks - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Growth Value: Is AtriCure Inc stock trending bullish2026 Selloffs & Real-Time Stock Movement Alerts - baoquankhu1.vn

Mar 17, 2026

Investor Mood: Should I hold or sell ABRPRF now2026 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn

Mar 17, 2026

Trading the Move, Not the Narrative: (ATRC) Edition - Stock Traders Daily

Mar 17, 2026

Mar 16, 2026

Insider Sell: Vinayak Doraiswamy Sells 5,000 Shares of AtriCure Inc (ATRC) - GuruFocus

Mar 16, 2026

Growth Value: Why is AtriCure Inc stock going downIndex Update & Growth Focused Investment Plans - baoquankhu1.vn

Mar 16, 2026

Analyst Calls: Will ANIK benefit from green energy policies2026 Breakouts & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Mar 16, 2026

AtriCure (NASDAQ:ATRC) Insider Vinayak Doraiswamy Sells 5,000 Shares - MarketBeat

Mar 16, 2026

AtriCure CSO Doraiswamy sells $149k in stock - Investing.com Nigeria

Mar 16, 2026

AtriCure CSO Doraiswamy sells $149k in stock By Investing.com - Investing.com Australia

Mar 16, 2026

AtriCure (ATRC) Chief Scientific Officer sells 5,000 shares at $29.83 - Stock Titan

Mar 16, 2026

First Light Asset Management LLC Sells 124,808 Shares of AtriCure, Inc. $ATRC - MarketBeat

Mar 16, 2026

Mar 13, 2026

Kennedy Capital Management LLC Boosts Stock Holdings in AtriCure, Inc. $ATRC - MarketBeat

Mar 13, 2026

Mar 12, 2026

ATRC (NASDAQ: ATRC) files Form 144 reporting proposed sale of award shares - Stock Titan

Mar 12, 2026

Director at AtriCure (NASDAQ: ATRC) exercises 10,000 stock options - Stock Titan

Mar 12, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI) - The Globe and Mail

Mar 12, 2026

Mar 11, 2026

AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates - Yahoo Finance

Mar 11, 2026

Mar 10, 2026

AtriCure at The Citizens Life Sciences Conference: Strategic Growth Outlook By Investing.com - Investing.com Canada

Mar 10, 2026

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 10, 2026

Mar 09, 2026

Moving Averages: Does AtriCure Inc have declining or rising EPS2026 Winners & Losers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Mar 08, 2026

Aug Opening: Is AtriCure Inc a cyclical or defensive stockEarnings Overview Summary & Daily Stock Trend Reports - baoquankhu1.vn

Mar 08, 2026

Mar 07, 2026

AtriCure, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo

Mar 07, 2026

AtriCure price target raised to $48 from $42 at JPMorgan - MSN

Mar 07, 2026

Energy Moves: Is AtriCure Inc stock trending bullish2025 Fundamental Recap & Community Verified Trade Alerts - baoquankhu1.vn

Mar 07, 2026

Quarterly Risk: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEARJuly 2025 Action & Accurate Intraday Trade Tips - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

ATRC Earnings History & Surprises | EPS & Revenue Results | ATRICURE INC (NASDAQ:ATRC) - ChartMill

Mar 06, 2026

Merger Talk: Will AtriCure Inc stock go up in YEAR2025 Biggest Moves & Fast Gain Swing Alerts - baoquankhu1.vn

Mar 06, 2026